|
|
|
|
|
|
|
|
|
Webinar: Establishing A Risk-Based Containment Strategy For High-Potency Micronization
|
As pharmaceutical pipelines advance increasingly potent compounds, containment is becoming critical to micronization strategy. This webinar explores a risk-based approach to high-potency micronization, from development through commercial scale. Discover how flexible containment and hard-wall isolators can work together to protect operators, maintain product quality, meet GMP expectations, and support scalable manufacturing. Explore practical strategies for smarter containment decisions at every stage. Click here to learn more.
|
|
|
|
|
|
Webinar | Abzena
|
Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.
|
|
|
|
|
|
Video | Adare Pharma Solutions
|
Tom Sellig, CEO, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
|
|
|
|
|
|
Video | AGC Biologics
|
Review the rapidly evolving world of complex drug development and the critical factors that drive success for products made using different molecules beyond the traditional antibodies.
|
|
|
|
|
|
Webinar | Upperton Pharma Solutions
|
Experts highlight spray drying as a gentle, scalable way to stabilize biologics, supporting high‑concentration injectables with controlled particles, sterility, and flexible delivery.
|
|
|
|
|
|
Video | West Pharmaceutical Services, Inc.
|
When regulations evolve, your suppliers’ ability to adapt shapes your ability to deliver. Watch how manufacturing, quality, and personnel standards combined with transparency make compliance an advantage.
|
|
|
|
|
|
Video | Outsourced Pharma
|
This segment of the Outsourced Pharma Live event, “Charting A Direct Pathway From Academia To CDMOs,” examines the red flags that can prevent a promising academic program from moving into external development.
|
|
|
| Connect With Outsourced Pharma: |
|
|
|
|
